# Randomized Double-blind Controlled Clinical Study of SGLT-2i Combined With Probiotic Preparations in Elderly Patients With HFpEF

> **NCT07687212** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **The First Affiliated Hospital of Air Force Medicial University** · enrollment: 162 (estimated)

## Conditions studied

- Heart Failure, Preserved Ejection Fraction

## Interventions

- **DRUG:** Henggliflozin Combined with Probiotics
- **DRUG:** Henggliflozin
- **DRUG:** double placebo

## Key facts

- **NCT ID:** NCT07687212
- **Lead sponsor:** The First Affiliated Hospital of Air Force Medicial University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2027-09
- **Final completion:** 2027-11
- **Target enrollment:** 162 (ESTIMATED)
- **Last updated:** 2026-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07687212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07687212, "Randomized Double-blind Controlled Clinical Study of SGLT-2i Combined With Probiotic Preparations in Elderly Patients With HFpEF". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07687212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*